Sort
85,873 grants matching “alzheimers”
Einstein Aging Study
$2,303,222Richard B. Lipton · Albert Einstein College Of Medicine · P01 · FY2006 · AG
A TIMEM252-dependent Microvascular Endophenotype in Alzheimerâs Disease
$2,302,768Zhen Zhao · University Of Southern California · RF1 · FY2021 · NS
Open Drug Discovery Center for Alzheimer's Disease
$2,302,254Allan I Levey · Emory University · U54 · FY2020 · AG
Genotyping the Understanding America Study to generate novel opportunities for research on cognitive functioning and dementia
$2,300,463Titus Johannes Galama · University Of Southern California · R01 · FY2024 · AG
A mechanistic and dyadic approach to identify how interpersonal conscientiousness supports cognitive health and lowers risk of dementia
$2,300,176Angelina R Sutin · Florida State University · RF1 · FY2023 · AG
Genetic Epidemiology and Multi-Omics Analyses in Familial and Sporadic Alzheimer's Disease Among Secular Caribbean Hispanics and Religious Order
$2,299,669Richard Mayeux · Columbia University Health Sciences · R01 · FY2020 · AG
Model-based cerebrovascular markers extracted from hemodynamic data for diagnosing MCI or AD and predicting disease progression.
$2,299,609Vasilis Z Marmarelis · University Of Southern California · R01 · FY2021 · AG
National Center for Drug Discovery in Neurodegeneration
$2,299,596Gregory D Cuny · Brigham And Women'S Hospital · U24 · FY2009 · NS
Developing a NAMPT activator for Alzheimerâs disease
$2,299,463Beibei Chen · University Of Pittsburgh At Pittsburgh · U01 · FY2025 · AG
Proteopathies of the Aging Central Nervous
$2,299,012J. David Gladstone Institutes · P01 · FY2004 · AG
CLINICAL PHARMACOKINETICS AND SAFETY TRIALS IN DOWN SYNDROME
$2,298,706Mara Becker · Duke University · N01 · FY2020 · HD
Biomarkers to Track Effective Interventions that Delay Dementia Onset in Participants of the "Risk Reduction for Alzheimer's Disease (rrAD)" Trial
$2,297,829Ann Marie Stowe · University Of Kentucky · RF1 · FY2023 · AG
Einstein Aging Study
$2,297,668Richard B. Lipton · Albert Einstein College Of Medicine · P01 · FY2008 · AG
Age-related changes of cognition in health and disease
$2,297,570Massachusetts General Hospital · P01 · FY2005 · AG
ncRNAs in plasma EVs of AD patients and their discriminatory power as biomarkers
$2,297,526Iliya Lefterov · University Of Pittsburgh At Pittsburgh · RF1 · FY2022 · AG
RADX INNOVATION FUNNEL FOR HEALTH TECHNOLOGIES - VALIDATION CENTER
$2,297,307Wilbur Lam · Emory University · N02 · FY2024 · HL
A Research Community Hub and Data Resource for Integrated Neuropathological and Omics Analysis of Alzheimer's disease.
$2,296,501Michael Hawrylycz · Allen Institute · U19 · FY2025 · AG
High-speed imaging of cortical and white matter microvascular flow in AD/ADRD models
$2,296,464Chris B Schaffer · Cornell University · RF1 · FY2022 · NS
Determine the role of atmospheric particulate matter pollutants in contributing to Lewy Body Dementia
$2,296,059Xiaobo Mao · Johns Hopkins University · RF1 · FY2023 · AG
Glucose homeostasis and the risk of Alzheimer's disease and Alzheimer's disease related dementias in the Multi-Ethnic Study of Atherosclerosis
$2,295,981Morgana Lee Mongraw-Chaffin · Wake Forest University Health Sciences · RF1 · FY2021 · AG
Project 2: Aging Healthy Together: Precision Profiles of Resilience and Risk
$2,295,709Lee Ryan · University Of Arizona · U19 · FY2024 · AG
Modulation Of Neuronal Channels and Receptors in the Brain
$2,295,615Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES
Multi-Ethnic Study of Atherosclerosis- Cellular Exosomes in Neurodegeneration and Dementia (MESA-CEND)
$2,295,557Gagan Deep · Wake Forest University Health Sciences · RF1 · FY2021 · AG
Implementation Science and Equity
$2,294,953Christie Befort · University Of Kansas Medical Center · P20 · FY2024 · GM
Alzheimer Disease Research Center
$2,294,686Helena Chang Chui · University Of Southern California · P50 · FY2008 · AG